Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain
  • A Study of MAS825 in Children and Adults with Still’s Disease to Test How Well It Works and How Safe It Is

    Recruiting

    2 1 1 1
    France Germany Italy The Netherlands Spain
  • Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

    Recruiting

    2 1 1 1
    Sweden
  • A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

    Recruiting

    2 1 1 1
    France Germany Italy Poland Spain
  • Study of romiplostim given before heart surgery in patients with low platelet counts to improve blood clotting after surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands
  • A study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Bulgaria Denmark Estonia Finland +13
  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    3 1
    Investigated Diseases:
    Bulgaria Croatia Czechia France Germany Greece +6
  • A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

    Recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark Finland France +9